Rx Name [MEROPENEM, 08120708]
|
|
EMSTAR 1G INJ (EMC/COL) MEROPENEM
|
|
|
|
|
|
08120708
|
|
|
CARBAPENEMS
|
|
|
Indicated as a single agent therapy for the treatment of complicated skin and skin structure infections due to Staphylococcus aureus (methicillin-susceptible isolates only),Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis,
|
|
|
Abdominal pain; diarrhoea; disturbances in liver function tests;
headache; nausea; pruritus; rash; thrombocy thaemia; vomiting. |
|
|
Adult: 0.5-1g every 8 hours
|
|
|
|
|
|
There are insufficient human data to establish whether there is a drug-associated risk of major birth defects or miscarriages with meropenem in pregnant women
|
|
|
Drug has been reported to be excreted in human milk; no information is available on effects of drug on breast-fed child or on milk production.
|
|
|
|